THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES;KITE PHARMA; INC.;KITE PHARMA, INC.
发明人:
BOT, ADRIAN,WIEZOREK, JEFFREY S.,GO, WILLIAM,JAIN, RAJUL,KOCHENDERFER, JAMES N.,ROSENBERG, STEVEN A.
申请号：
CA2986798
公开号：
CA2986798A1
申请日:
2016.05.27
申请国别(地区):
CA
年份:
2016
代理人:
摘要：
The invention provides methods of increasing the efficacy of a T cell therapy in a patient in need thereof. The invention includes a method of conditioning a patient prior to a T cell therapy, wherein the conditioning involves administering a combination of cyclophosphamide and fludarabine.
